Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2024

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has announced that management will present at … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

Astrotech Corp. (NASDAQ: ASTC) Subsidiary, “1st Detect”, Focuses on Superior Narcotics Trace Detection For Airport and Other Security Sites

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. With recent approval as a U.S. General Services Administration (“GSA”) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000, … Continue reading

Posted in Astrotech Corp. ASTC | Leave a comment

Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use

Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases such as ALS and multiple sclerosis (“MS”), recently announced significant updates to their ACT-EAP for … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) CEO Calls on Business Leaders to Adopt Joint AI and Quantum Strategies

As artificial intelligence (“AI”) continues its rapid enterprise adoption trend, there is growing interest in how quantum computing can be used in conjunction with AI to create better, more cost- and energy-effective solutions in various fields, such as material science, … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceuticals and technology, is reporting its first-quarter 2024 revenues. According to the report, the company saw revenues of $408,532 while also strengthening its balance sheet with the completion of an $8.4 million private … Continue reading

Posted in Nutriband Inc. NTRB | Leave a comment